|
Volumn 12, Issue 4, 2007, Pages 297-299
|
PI3 Kinase Activation and Response to Trastuzumab Therapy: What's neu with Herceptin Resistance?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LAPATINIB;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
TRASTUZUMAB;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG SENSITIVITY;
ENZYME ACTIVATION;
GENE AMPLIFICATION;
GENE IDENTIFICATION;
GENETIC SCREENING;
HUMAN;
MISSENSE MUTATION;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RNA INTERFERENCE;
SHORT SURVEY;
STATISTICAL SIGNIFICANCE;
|
EID: 35148854641
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccr.2007.10.004 Document Type: Short Survey |
Times cited : (53)
|
References (11)
|